Arrowhead Pharmaceuticals (ARWR) Change in Cash (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Change in Cash of -$14.1 million for Q1 2026, up 43.53% on a QoQ basis from -$25.0 million in Q4 2025, and down 110.68% year-over-year from $132.2 million in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Change in Cash (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Change in Cash history runs 17 years deep, the most recent figure standing at -$14.1 million for Q1 2026.
- Quarterly Change in Cash fell 110.68% year-over-year to -$14.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 96.99% YoY) and the FY2025 annual result came in at $124.3 million, up 1101.89% from the prior year.
- Change in Cash was -$14.1 million for Q1 2026 at Arrowhead Pharmaceuticals, up from -$25.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $132.2 million in Q1 2025 and bottomed at -$67.2 million in Q1 2023.
- A 5-year average of $5.4 million and a median of -$14.1 million in 2026 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash tumbled 1197.61% — and 2024, when it surged 435.71%.
- Arrowhead Pharmaceuticals' Change in Cash stood at $94.4 million in 2022, then plunged by 155.88% to -$52.7 million in 2023, then rose by 7.6% to -$48.7 million in 2024, then surged by 48.67% to -$25.0 million in 2025, then soared by 43.53% to -$14.1 million in 2026.
- Business Quant data shows ARWR's Change in Cash at -$14.1 million in Q1 2026, -$25.0 million in Q4 2025, and $96.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | -14.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.12 Mn |
| Dec 31, 2025 | -25.01 Mn |
| Sep 30, 2025 | 96.78 Mn |
| Jun 30, 2025 | -56.01 Mn |
| Mar 31, 2025 | 132.22 Mn |
| Dec 31, 2024 | -48.73 Mn |
| Sep 30, 2024 | 28.95 Mn |
| Jun 30, 2024 | -58.08 Mn |
| Mar 31, 2024 | 69.46 Mn |
| Dec 31, 2023 | -52.73 Mn |
| Sep 30, 2023 | 5.40 Mn |
| Jun 30, 2023 | -29.55 Mn |
| Mar 31, 2023 | -67.22 Mn |
| Dec 31, 2022 | 94.37 Mn |
| Sep 30, 2022 | -31.44 Mn |
| Jun 30, 2022 | 53.06 Mn |
| Mar 31, 2022 | -5.18 Mn |
| Dec 31, 2021 | -92.81 Mn |
| Sep 30, 2021 | -141.46 Mn |
| Jun 30, 2021 | -46.40 Mn |